Mabel LaForgia, DNP, RN, CNL
Jersey City Medical Center,Jersey City, NJ
Authored Items
November 13, 2020 | November 2020 Vol 11, No 11
Early-stage and hormone receptor–positive breast cancers may need additional genomic testing to determine which patients need chemotherapy in addition to endocrine therapy.
Last modified: November 13, 2020